Gilead Sciences Inc. has slapped Teva Pharmaceuticals Industries Ltd. with a patent infringement suit after the Israeli generic-drug maker filed an application to market a generic version of the HIV treatment Truvada.
Please update your browser to visit this Perma Link.
Perma.cc has been tested with the latest version of:
Google Chrome, Mozilla Firefox, Apple Safari and Microsoft Edge.